Showing results (1671-1680 of 2,184) with videos related to

Sort By:
Pageof 219
Public Health Action|October 4, 2019
Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012-2017E K Lavu, K Johnson, J Banamu, et al.
Human Brain Mapping|November 6, 2012
Three-dimensional surface deformation-based shape analysis of hippocampus and caudate nucleus in children with fetal alcohol spectrum disordersJesuchristopher Joseph, Christopher Warton, Sandra W Jacobson, et al.
BJA Open|August 17, 2023
Evaluation of the Analgesia Nociception Index and videopupillometry to predict post-tonsillectomy morphine requirements in children: a single-centre, prospective interventional studyBruno Evrard, Cyrielle Lefebvre, Paul Spiry, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2021
T cell immune awakening in response to immunotherapy is age-dependentZena Salih, Antonia Banyard, Joshua Tweedy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2022
Cognitive Impairment in Tuberculous MeningitisAngharad G Davis, Anna J Dreyer, Christine Albertyn, et al.
Harm Reduction Journal|December 3, 2022
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluationAmy Corneli, Brian Perry, Andrea Des Marais, et al.
Microbial Genomics|January 10, 2018
Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decadesArnold Bainomugisa, Evelyn Lavu, Stenard Hiashiri, et al.
British Journal of Haematology|February 6, 2007
Epstein-Barr virus early-antigen antibodies before allogeneic haematopoietic stem cell transplantation as a marker of risk of post-transplant lymphoproliferative disordersFelix Agbalika, Jerome Larghero, Helene Esperou, et al.
Journal of Medicinal Chemistry|April 13, 2012
Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)Simon Michaelis, Anett Marais, Anna K Schrey, et al.
Pigment Cell & Melanoma Research|December 17, 2009
Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethalityNathalie Dhomen, Silvy Da Rocha Dias, Robert Hayward, et al.
Pageof 219